Financial Year |
March 31 2023 |
Monetary Funds |
2,383,882,038.81 |
Held-for-trading Financial Assets |
50,000,000.00 |
Notes Receivable |
5,817,600.00 |
Accounts Receivable |
1,327,562,671.33 |
Advances to Suppliers |
675,144,560.85 |
Other Receivables |
109,374,667.31 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
18,269,541.29 |
Inventories |
4,520,131,732.03 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
1,403,719.37 |
Other Current Assets |
209,648,978.13 |
Total Current Assets |
10,220,610,023.30 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
573,105,240.02 |
Investment Properties |
-- |
Fixed Assetes |
752,504,558.01 |
Under-construction Projects |
282,299,989.87 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
332,374,268.92 |
R&D expenses |
-- |
Goodwill |
285,263,770.08 |
Long-Term Deferred and Prepaid Expenses |
4,119,799.82 |
Deferred Income Tax Assets |
161,905,605.43 |
Other Non-Current Assets |
389,565,913.69 |
Sub-Total of Non-Current Assets |
5,716,346,138.77 |
Total Assets |
15,936,956,162.07 |
Short-Term Loans |
2,059,830,490.67 |
Trading Financial liabilities |
-- |
Notes Payable |
60,444,956.57 |
Accounts Payable |
531,406,424.22 |
Accounts Received In Advance |
10,462,829.56 |
Employee Compensation Payable |
158,481,618.33 |
Taxes Payable |
238,250,664.75 |
Interest Payable |
-- |
Dividend Payable |
38,419,681.79 |
Other payables |
149,796,123.55 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
621,488,831.15 |
Other Current Liabilities |
599,368,338.61 |
Sub-Total of Current Liabilities |
4,864,629,769.73 |
Long-term Loans |
530,797,614.58 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
44,976,960.00 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
27,847,949.99 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
632,974,126.33 |
Total Liabilities |
5,497,603,896.06 |
Paid-In Capital(Or Share Stock) |
1,752,826,570.00 |
Capital Surplus |
2,079,209,827.54 |
Surplus Reserve |
53,225,125.13 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
4,141,724,403.30 |
Minority Stockholder's Interest |
828,123,169.66 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,611,229,096.35 |
Owner's Equity(Stockholder's Equity) |
10,439,352,266.01 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
15,936,956,162.07 |